InsiderClue
Insiders · Profile

Frazier Life Sciences IX, L.P.

10% owner at Tarsus Pharmaceuticals · 10% owner at Passage BIO · 10% owner at Phathom Pharmaceuticals · and 1 more. Filing since 22 Jul 2019. CIK 0001720320

TARS Tarsus Pharmaceuticals, Inc. 10% owner · 1 trade PASG Passage BIO, Inc. 10% owner · 1 trade PHAT Phathom Pharmaceuticals, Inc. 10% owner · 1 trade MIRM Mirum Pharmaceuticals, Inc. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
TARS Tarsus Pharmaceuticals, Inc.
20 Oct 2020
10% owner
Bought
312,500
$5.00M
19.5%
PASG Passage BIO, Inc.
3 Mar 2020
10% owner
Bought
550,000
$9.90M
12.3%
PHAT Phathom Pharmaceuticals, Inc.
29 Oct 2019
10% owner
Bought
1,052,631
$20.00M
16.9%
MIRM Mirum Pharmaceuticals, Inc.
22 Jul 2019
10% owner
Bought
450,000
$6.75M
14.4%
4 decisions on file.